Clinical Trial Update: MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease

View source ↗

Summary

The clinical trial evaluating microRNAs as diagnostic and predictive biomarkers for acute graft-versus-host disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Northwell Health | Conditions: Acute GVH Disease | Status: WITHDRAWN